with exciting developments at the Conference on Retroviruses and Opportunistic Infections 2025, including new long-acting therapies for treatment and prevention that could last up to 2 years.

The phase 2 study – reported at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado – looked at the combination of MSD’s experimental long-acting reverse ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The conference highlighted recent issues in vaccine safety, including the history and design of a vaccine for rotavirus. Other topics included discussions of the synergies between veterinary and ...

The development of penicillin and its efficacy in the treatment of syphilis transformed syphilis management for many with and at risk for infection. However, problems such as beta-lactam allergies ...

Opportunistic infection or cancer occurred in a small number of patients treated with mirikizumab. (Funded by Eli Lilly; LUCENT-1 and LUCENT-2 ClinicalTrials.gov numbers, NCT03518086 and ...

The main symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent respiratory infections, and lack of energy, which typically start mild but ...

The final four is set in the 2025 NBA playoff bracket, and the conference finals are underway. The Oklahoma City Thunder are up 2-0 in the Western Conference finals against the Minnesota ...

Infectious Disease News - Find the latest infectious disease news articles, videos, blogs, books, Continuing Medical Education (CME), meeting coverage, and journal articles.

Abstract: With the advancement in communication technologies in the last decade, mobile opportunistic networks (MONs) have received significant attention in facilitating spontaneous communication. Due ...